BENAROYA RESEARCH INSTITUTE AT VIRGINIA MASON: Form 990, tax year 2012
View the entire original 990 at ProPublica ↗
- Organization
- BENAROYA RESEARCH INSTITUTE AT VIRGINIA MASON (EIN 91-0653422)
- Tax period
- 2012-01-01 to 2012-12-31
- Filed
- 2013-11-13
- IRS object ID
- 201323179349306202
- Schema version
- 2012v2.2
- Source
- Download XML · Original 990 at ProPublica
Every field in the e-filed return. Faint text is the IRS element name, for citing.
- Return header
- Form 990
- Schedule A
- Schedule B
- Schedule C
- Schedule D
- Schedule F
- Schedule I
- Schedule J
- Schedule K
- Schedule O
- Schedule R
- Affiliated Group Schedule
Return header ReturnHeader
| Field | Value | IRS element (for citing) |
|---|---|---|
| Timestamp | 2013-11-13T03:22:27-00:00 | Timestamp |
| Tax Period End Date | 2012-12-31 | TaxPeriodEndDate |
Preparer Firm PreparerFirm
Preparer Firm Business Name PreparerFirmBusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | KPMG LLP | BusinessNameLine1 |
Preparer Firm US Address PreparerFirmUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 1918 8th Avenue Suite 2900 | AddressLine1 |
| City | Seattle | City |
| State | WA | State |
| ZIP Code | 98101 | ZIPCode |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return Type | 990 | ReturnType |
| Tax Period Begin Date | 2012-01-01 | TaxPeriodBeginDate |
Filer Filer
| Field | Value | IRS element (for citing) |
|---|---|---|
| EIN | 910653422 | EIN |
Name Name
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | Benaroya Research Institute at Virginia Mason | BusinessNameLine1 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Name Control | BENA | NameControl |
| Phone | 2063426500 | Phone |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 1201 Ninth Avenue | AddressLine1 |
| City | Seattle | City |
| State | WA | State |
| ZIP Code | 981012795 | ZIPCode |
Officer Officer
| Field | Value | IRS element (for citing) |
|---|---|---|
| Name | Homer W Lane Jr | Name |
| Title | Executive DirectorCFO | Title |
| Date Signed | 2013-11-08 | DateSigned |
| Authorize Third Party | true | AuthorizeThirdParty |
Preparer Preparer
| Field | Value | IRS element (for citing) |
|---|---|---|
| Name | Sue Robison | Name |
| Phone | 2069134000 | Phone |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Tax Year | 2012 | TaxYear |
| Build TS | 2016-02-24 21:20:13Z | BuildTS |
Form 990 IRS990
| Field | Value | IRS element (for citing) |
|---|---|---|
| Name Of Principal Officer Person | Gerald Nepom MD PhD | NameOfPrincipalOfficerPerson |
Address Principal Officer US AddressPrincipalOfficerUS
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 1201 Ninth Avenue | AddressLine1 |
| City | Seattle | City |
| State | WA | State |
| ZIP Code | 98101 | ZIPCode |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gross Receipts | 43591930 | GrossReceipts |
| Group Return For Affiliates | false | GroupReturnForAffiliates |
| Organization501c3 | X | Organization501c3 |
| Web Site | http://www.benaroyaresearch.org | WebSite |
| Type Of Organization Corporation | X | TypeOfOrganizationCorporation |
| Year Formation | 1956 | YearFormation |
| State Legal Domicile | WA | StateLegalDomicile |
| Activity Or Mission Description | To conduct and encourage high quality medical, surgical, and scientific research and research training in disease and problems of medical importance. | ActivityOrMissionDescription |
| Nbr Voting Members Governing Body | 22 | NbrVotingMembersGoverningBody |
| Nbr Independent Voting Members | 17 | NbrIndependentVotingMembers |
| Total Nbr Employees | 304 | TotalNbrEmployees |
| Total Nbr Volunteers | 17 | TotalNbrVolunteers |
| Total Gross UBI | 0 | TotalGrossUBI |
| Contributions Grants Prior Year | 34328409 | ContributionsGrantsPriorYear |
| Contributions Grants Current Year | 38329362 | ContributionsGrantsCurrentYear |
| Program Service Revenue Prior Year | 2391006 | ProgramServiceRevenuePriorYear |
| Program Service Revenue CY | 4701834 | ProgramServiceRevenueCY |
| Investment Income Prior Year | 10695 | InvestmentIncomePriorYear |
| Investment Income Current Year | 10130 | InvestmentIncomeCurrentYear |
| Other Revenue Prior Year | 612301 | OtherRevenuePriorYear |
| Other Revenue Current Year | 349689 | OtherRevenueCurrentYear |
| Total Revenue Prior Year | 37342411 | TotalRevenuePriorYear |
| Total Revenue Current Year | 43391015 | TotalRevenueCurrentYear |
| Grants And Similar Amnts Prior Year | 4194908 | GrantsAndSimilarAmntsPriorYear |
| Grants And Similar Amnts CY | 4202339 | GrantsAndSimilarAmntsCY |
| Benefits Paid To Members CY | 0 | BenefitsPaidToMembersCY |
| Salaries Etc Prior Year | 20801358 | SalariesEtcPriorYear |
| Salaries Etc Current Year | 22311686 | SalariesEtcCurrentYear |
| Total Prof Fundrsng Exp CY | 0 | TotalProfFundrsngExpCY |
| Total Fundrsng Exp Current Year | 0 | TotalFundrsngExpCurrentYear |
| Other Expense Prior Year | 13165395 | OtherExpensePriorYear |
| Other Expenses Current Year | 17131610 | OtherExpensesCurrentYear |
| Total Expenses Prior Year | 38161661 | TotalExpensesPriorYear |
| Total Expenses Current Year | 43645635 | TotalExpensesCurrentYear |
| Revenues Less Expenses Prior Year | -819250 | RevenuesLessExpensesPriorYear |
| Revenues Less Expenses CY | -254620 | RevenuesLessExpensesCY |
| Total Assets BOY | 69664646 | TotalAssetsBOY |
| Total Assets EOY | 75528821 | TotalAssetsEOY |
| Total Liabilities BOY | 35554255 | TotalLiabilitiesBOY |
| Total Liabilities EOY | 40430952 | TotalLiabilitiesEOY |
| Net Assets Or Fund Balances BOY | 34110391 | NetAssetsOrFundBalancesBOY |
| Net Assets Or Fund Balances EOY | 35097869 | NetAssetsOrFundBalancesEOY |
| Info In Schedule O Part III | X | InfoInScheduleOPartIII |
| Mission Description | See Schedule O | MissionDescription |
| Significant New Program Services | false | SignificantNewProgramServices |
| Significant Change | false | SignificantChange |
| Expense | 35079287 | Expense |
| Grants | 4202339 | Grants |
| Revenue | 4701834 | Revenue |
| Description | BRI is an international leader in immune system and autoimmune disease research including Type 1 diabetes, arthritis, lupus, multiple sclerosis, and scleroderma. Additional information is provided in Schedule O. | Description |
| Total Program Service Expense | 35079287 | TotalProgramServiceExpense |
| Described In501 C3 | true | DescribedIn501C3 |
| Schedule B Required | true | ScheduleBRequired |
| Political Activities | false | PoliticalActivities |
| Lobbying Activities | true | LobbyingActivities |
| Donor Advised Funds | false | DonorAdvisedFunds |
| Conservation Easements | false | ConservationEasements |
| Collections Of Art | false | CollectionsOfArt |
| Credit Counseling | false | CreditCounseling |
| Term Or Permanent Endowments | false | TermOrPermanentEndowments |
| Report Land Bldg Equip | true | ReportLandBldgEquip |
| Report Invest Oth Securities | false | ReportInvestOthSecurities |
| Report Prog Rel Invest | false | ReportProgRelInvest |
| Report Other Assets | true | ReportOtherAssets |
| Report Other Liabilities | false | ReportOtherLiabilities |
| Report Fin48 Footnote | false | ReportFin48Footnote |
| Independent Audit Financial Stmt | true | IndependentAuditFinancialStmt |
| Consolidated Audit Financial Stmt | false | ConsolidatedAuditFinancialStmt |
| School | false | School |
| Foreign Office | false | ForeignOffice |
| Foreign Activities | true | ForeignActivities |
| More Than5000 K To Organizations | true | MoreThan5000KToOrganizations |
| More Than5000 K To Individuals | false | MoreThan5000KToIndividuals |
| Professional Fundraising | false | ProfessionalFundraising |
| Fundraising Activities | false | FundraisingActivities |
| Gaming | false | Gaming |
| Hospital | false | Hospital |
| Grants To Organizations | true | GrantsToOrganizations |
| Grants To Individuals | false | GrantsToIndividuals |
| Schedule J Required | true | ScheduleJRequired |
| Tax Exempt Bonds | true | TaxExemptBonds |
| Invest Tax Exempt Bonds | false | InvestTaxExemptBonds |
| Escrow Account | false | EscrowAccount |
| On Behalf Of Issuer | true | OnBehalfOfIssuer |
| Excess Benefit Transaction | false | ExcessBenefitTransaction |
| Prior Excess Benefit Transaction | false | PriorExcessBenefitTransaction |
| Loan To Officer Or DQP | false | LoanToOfficerOrDQP |
| Grant To Related Person | false | GrantToRelatedPerson |
| Bsnss Rltnshp With Organization | false | BsnssRltnshpWithOrganization |
| Bsnss Rltnshp Thru Family Member | false | BsnssRltnshpThruFamilyMember |
| Officer Entity With Bsnss Rltnshp | false | OfficerEntityWithBsnssRltnshp |
| Deductible Non Cash Contributions | false | DeductibleNonCashContributions |
| Deductible Contributions Of Art | false | DeductibleContributionsOfArt |
| Terminated | false | Terminated |
| Partial Liquidation | false | PartialLiquidation |
| Disregarded Entity | false | DisregardedEntity |
| Related Entity | true | RelatedEntity |
| Related Org Controlled Entity | false | RelatedOrgControlledEntity |
| Transaction Related Entity | false | TransactionRelatedEntity |
| Transfers To Exempt Non Chrtbl Org | false | TransfersToExemptNonChrtblOrg |
| Activities Conducted Partnership | false | ActivitiesConductedPartnership |
| Schedule O Required | true | ScheduleORequired |
| Number Forms Transmitted With1096 | 47 | NumberFormsTransmittedWith1096 |
| Number W2 G Included | 0 | NumberW2GIncluded |
| Compliance With Backup Witholding | true | ComplianceWithBackupWitholding |
| Number Of Employees | 304 | NumberOfEmployees |
| Employment Tax Returns Filed | true | EmploymentTaxReturnsFiled |
| Unrelated Business Income | false | UnrelatedBusinessIncome |
| Foreign Financial Account | false | ForeignFinancialAccount |
| Prohibited Tax Shelter Trans | false | ProhibitedTaxShelterTrans |
| Taxable Party Notification | false | TaxablePartyNotification |
| Non Deductible Contributions | false | NonDeductibleContributions |
| Quid Pro Quo Contributions | false | QuidProQuoContributions |
| Form8282 Property Disposed Of | false | Form8282PropertyDisposedOf |
| Funds To Pay Premiums | false | FundsToPayPremiums |
| Premiums Paid | false | PremiumsPaid |
| Indoor Tanning Services | false | IndoorTanningServices |
| Info In Schedule O Part VI | X | InfoInScheduleOPartVI |
| Nbr Voting Governing Body Members | 22 | NbrVotingGoverningBodyMembers |
| Number Independent Voting Members | 17 | NumberIndependentVotingMembers |
| Family Or Business Relationship | false | FamilyOrBusinessRelationship |
| Delegation Of Management Duties | false | DelegationOfManagementDuties |
| Changes To Organizing Docs | false | ChangesToOrganizingDocs |
| Material Diversion Or Misuse | false | MaterialDiversionOrMisuse |
| Members Or Stockholders | true | MembersOrStockholders |
| Election Of Board Members | true | ElectionOfBoardMembers |
| Decisions Subject To Approval | true | DecisionsSubjectToApproval |
| Minutes Of Governing Body | true | MinutesOfGoverningBody |
| Minutes Of Committees | true | MinutesOfCommittees |
| Officer Mailing Address | false | OfficerMailingAddress |
| Local Chapters | false | LocalChapters |
| Form990 Provided To Governing Body | true | Form990ProvidedToGoverningBody |
| Conflict Of Interest Policy | true | ConflictOfInterestPolicy |
| Annual Disclosure Covered Persons | true | AnnualDisclosureCoveredPersons |
| Regular Monitoring Enforcement | true | RegularMonitoringEnforcement |
| Whistleblower Policy | true | WhistleblowerPolicy |
| Document Retention Policy | true | DocumentRetentionPolicy |
| Compensation Process CEO | true | CompensationProcessCEO |
| Compensation Process Other | true | CompensationProcessOther |
| Investment In Joint Venture | false | InvestmentInJointVenture |
| States Where Copy Of Return Is Filed | WA | StatesWhereCopyOfReturnIsFiled |
| Upon Request | X | UponRequest |
The Books Are In Care Of TheBooksAreInCareOf
| Field | Value | IRS element (for citing) |
|---|---|---|
| Name Person | Homer W Lane Jr Executive DirectorC | NamePerson |
| Telephone Number | 2063426508 | TelephoneNumber |
Address US AddressUS
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 1201 Ninth Avenue | AddressLine1 |
| City | Seattle | City |
| State | WA | State |
| ZIP Code | 981012795 | ZIPCode |
Form990 Part VII Section A Form990PartVIISectionA (29 entries)
| TitleTitle | Average Hours Per WeekAverageHoursPerWeek | Individual Trustee Or DirectorIndividualTrusteeOrDirector | Reportable Comp From OrganizationReportableCompFromOrganization | Reportable Comp From Related OrgsReportableCompFromRelatedOrgs | Other CompensationOtherCompensation | Average Hours Per Week RelatedAverageHoursPerWeekRelated | OfficerOfficer | Key EmployeeKeyEmployee | Highest Compensated EmployeeHighestCompensatedEmployee |
|---|---|---|---|---|---|---|---|---|---|
| Carla Greenbaum MD | |||||||||
| Director | 040.00 | X | 205255 | 0 | 30903 | ||||
| Gerald Nepom MD PhD | |||||||||
| Ex Officio | 040.00 | X | 471408 | 0 | 41336 | ||||
| Joyce Lammert MD PhD | |||||||||
| Director | 001.00 | X | 0 | 564202 | 48492 | 050.00 | |||
| John Corman MD | |||||||||
| Director | 001.00 | X | 0 | 500585 | 69457 | 050.00 | |||
| Gary Kaplan MD | |||||||||
| Ex Officio | 001.00 | X | 0 | 1507637 | 2230041 | 054.00 | |||
| Tom Cohen | |||||||||
| Director | 001.00 | X | 0 | 0 | 0 | ||||
| Rebecca Campbell | |||||||||
| Director | 001.00 | X | 0 | 0 | 0 | ||||
| Kristi Pangrazio | |||||||||
| Chairman | 001.00 | X | 0 | 0 | 0 | 004.00 | X | ||
| Margaret Morrow | |||||||||
| Secretary | 001.00 | X | 0 | 0 | 0 | X | |||
| Miriam Sevy | |||||||||
| Treasurer | 001.00 | X | 0 | 0 | 0 | X | |||
| Frank Dvorak PhD | |||||||||
| Director | 001.00 | X | 0 | 0 | 0 | ||||
| Trish Markey | |||||||||
| Director | 001.00 | X | 0 | 0 | 0 | ||||
| Stuart Klorfine | |||||||||
| Director | 001.00 | X | 0 | 0 | 0 | ||||
| Edward Drosdick | |||||||||
| Director | 001.00 | X | 0 | 0 | 0 | ||||
| Thomas Kelly | |||||||||
| Director | 001.00 | X | 0 | 0 | 0 | ||||
| Ditman Johnson | |||||||||
| Director | 001.00 | X | 0 | 0 | 0 | ||||
| Gaylia Meitzen | |||||||||
| Director | 001.00 | X | 0 | 0 | 0 | ||||
| Michael Gallatin | |||||||||
| Director | 001.00 | X | 0 | 0 | 0 | ||||
| Jessica Muffett | |||||||||
| Director | 001.00 | X | 0 | 0 | 0 | ||||
| Carla DewBerry | |||||||||
| Vice Chairman | 001.00 | X | 0 | 0 | 0 | X | |||
| Ann Sobil | |||||||||
| Director | 001.00 | X | 0 | 0 | 0 | ||||
| Christopher Wilson MD | |||||||||
| Director | 001.00 | X | 0 | 0 | 0 | ||||
| Homer Lane Jr | |||||||||
| Executive Director and Chief Financial Officer | 040.00 | 209238 | 0 | 17912 | X | ||||
| Jack Nagan | |||||||||
| Executive Director | 040.00 | 295162 | 0 | 29496 | X | ||||
| Jane Buckner MD | |||||||||
| Research Member | 040.00 | 210116 | 0 | 25056 | X | ||||
| William Kwok PhD | |||||||||
| Research Member | 040.00 | 202591 | 0 | 26352 | X | ||||
| Jason Wood | |||||||||
| Chief Information Officer | 040.00 | 168902 | 0 | 13639 | X | ||||
| Thomas Wight PhD | |||||||||
| Research Member | 040.00 | 176017 | 0 | 37376 | X | ||||
| Steven Ziegler PhD | |||||||||
| Research Member | 040.00 | 183162 | 0 | 19651 | X | ||||
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Reportable Comp From Org | 2121851 | TotalReportableCompFromOrg |
| Total Reportable Comp Frm Rltd Orgs | 2572424 | TotalReportableCompFrmRltdOrgs |
| Total Other Compensation | 2589711 | TotalOtherCompensation |
| Number Individuals GT100 K | 33 | NumberIndividualsGT100K |
| Formers Listed | false | FormersListed |
| Total Comp GT150 K | true | TotalCompGT150K |
| Compensation From Other Sources | false | CompensationFromOtherSources |
Contractor Compensation ContractorCompensation (3 entries)
| Address Line1AddressOfContractor/AddressUS/AddressLine1 | CityAddressOfContractor/AddressUS/City | StateAddressOfContractor/AddressUS/State | ZIP CodeAddressOfContractor/AddressUS/ZIPCode | Description Of ServicesDescriptionOfServices | CompensationCompensation |
|---|---|---|---|---|---|
| Davis Wright Tremaine LLP | |||||
| 1201 Third Ave Ste 2200 | Seattle | WA | 98101 | Consulting | 160836 |
| DNA Brand Mechanics | |||||
| 1301 Fifth Ave Suite 2600 | Seattle | WA | 98101 | Consulting | 136491 |
| KPMG LLP | |||||
| 1918 Eighth Ave Suite 2900 | Seattle | WA | 98101 | Auditing Consulting | 111175 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Number Of Contractors GT100 K | 3 | NumberOfContractorsGT100K |
| Related Organizations | 4843000 | RelatedOrganizations |
| Government Grants | 25250569 | GovernmentGrants |
| All Other Contributions | 8235793 | AllOtherContributions |
| Total Contributions | 38329362 | TotalContributions |
Program Service Revenue ProgramServiceRevenue (2 entries)
| DescriptionDescription | Business CodeBusinessCode | Total Revenue ColumnTotalRevenueColumn | Related Or Exempt Function IncomeRelatedOrExemptFunctionIncome |
|---|---|---|---|
| Sponsored research | 621500 | 3113096 | 3113096 |
| Core services | 621500 | 1588738 | 1588738 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Program Service Revenue | 4701834 | TotalProgramServiceRevenue |
Investment Income InvestmentIncome
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | 10130 | TotalRevenueColumn |
| Exclusion | $10,130 | ExclusionAmount |
Gross Rents GrossRents
| Field | Value | IRS element (for citing) |
|---|---|---|
| Real | 550604 | Real |
Less Rental Expenses LessRentalExpenses
| Field | Value | IRS element (for citing) |
|---|---|---|
| Real | 200915 | Real |
Rental Income Or Loss RentalIncomeOrLoss
| Field | Value | IRS element (for citing) |
|---|---|---|
| Real | 349689 | Real |
Net Rental Income Or Loss NetRentalIncomeOrLoss
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | 349689 | TotalRevenueColumn |
| Exclusion | $348,689 | ExclusionAmount |
Total Revenue TotalRevenue
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | 43391015 | TotalRevenueColumn |
| Related Or Exempt Function Income | 4701834 | RelatedOrExemptFunctionIncome |
| Exclusion | $358,819 | ExclusionAmount |
Grants To Domestic Orgs GrantsToDomesticOrgs
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 3994654 | Total |
| Program Services | 3994654 | ProgramServices |
Grants To Domestic Individuals GrantsToDomesticIndividuals
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 0 | Total |
Foreign Grants ForeignGrants
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 207685 | Total |
| Program Services | 207685 | ProgramServices |
Benefits To Members BenefitsToMembers
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 0 | Total |
Comp Current Officers Directors CompCurrentOfficersDirectors
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 2121071 | Total |
| Program Services | 1357288 | ProgramServices |
| Management And General | 763783 | ManagementAndGeneral |
Comp Disqual Persons CompDisqualPersons
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 0 | Total |
Other Salaries And Wages OtherSalariesAndWages
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 15190630 | Total |
| Program Services | 11840644 | ProgramServices |
| Management And General | 3349986 | ManagementAndGeneral |
Pension Plan Contributions PensionPlanContributions
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 1232381 | Total |
| Program Services | 910782 | ProgramServices |
| Management And General | 321599 | ManagementAndGeneral |
Other Employee Benefits OtherEmployeeBenefits
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 2640144 | Total |
| Program Services | 1951179 | ProgramServices |
| Management And General | 688965 | ManagementAndGeneral |
Payroll Taxes PayrollTaxes
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 1127460 | Total |
| Program Services | 833241 | ProgramServices |
| Management And General | 294219 | ManagementAndGeneral |
Fees For Services Management FeesForServicesManagement
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 0 | Total |
Fees For Services Legal FeesForServicesLegal
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 32454 | Total |
| Management And General | 32454 | ManagementAndGeneral |
Fees For Services Accounting FeesForServicesAccounting
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 83675 | Total |
| Management And General | 83675 | ManagementAndGeneral |
Fees For Services Lobbying FeesForServicesLobbying
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 0 | Total |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Fees For Services Prof Fundraising | FeesForServicesProfFundraising |
Fees For Services Invst Mgmnt Fees FeesForServicesInvstMgmntFees
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 0 | Total |
Fees For Services Other FeesForServicesOther
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 1416385 | Total |
| Program Services | 818301 | ProgramServices |
| Management And General | 598084 | ManagementAndGeneral |
Advertising Advertising
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 186521 | Total |
| Management And General | 186521 | ManagementAndGeneral |
Office Expenses OfficeExpenses
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 192197 | Total |
| Program Services | 27749 | ProgramServices |
| Management And General | 164448 | ManagementAndGeneral |
Information Technology InformationTechnology
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 514670 | Total |
| Program Services | 116001 | ProgramServices |
| Management And General | 398669 | ManagementAndGeneral |
Royalties Royalties
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 0 | Total |
Occupancy Occupancy
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 2199825 | Total |
| Program Services | 1946322 | ProgramServices |
| Management And General | 253503 | ManagementAndGeneral |
Travel Travel
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 297916 | Total |
| Program Services | 253584 | ProgramServices |
| Management And General | 44332 | ManagementAndGeneral |
Travel Entrtnmnt Public Officials TravelEntrtnmntPublicOfficials
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 0 | Total |
Conferences Meetings ConferencesMeetings
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 66563 | Total |
| Program Services | 54434 | ProgramServices |
| Management And General | 12129 | ManagementAndGeneral |
Interest Interest
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 918270 | Total |
| Program Services | 804680 | ProgramServices |
| Management And General | 113590 | ManagementAndGeneral |
Payments To Affiliates PaymentsToAffiliates
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 0 | Total |
Depreciation Depletion DepreciationDepletion
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 2528926 | Total |
| Program Services | 2003391 | ProgramServices |
| Management And General | 525535 | ManagementAndGeneral |
Insurance Insurance
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 50342 | Total |
| Management And General | 50342 | ManagementAndGeneral |
Other Expenses OtherExpenses (4 entries)
| DescriptionDescription | TotalTotal | Program ServicesProgramServices | Management And GeneralManagementAndGeneral |
|---|---|---|---|
| Supplies | 4171778 | 3918362 | 253416 |
| Other Purchased Services | 174446 | 141603 | 32843 |
| Patient Costs | 914920 | 914920 | |
| Research Participants Fee | 163197 | 163197 |
All Other Expenses AllOtherExpenses
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 3219525 | Total |
| Program Services | 2821270 | ProgramServices |
| Management And General | 398255 | ManagementAndGeneral |
Total Functional Expenses TotalFunctionalExpenses
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 43645635 | Total |
| Program Services | 35079287 | ProgramServices |
| Management And General | 8566348 | ManagementAndGeneral |
| Fundraising | 0 | Fundraising |
Savings And Temp Cash Investments SavingsAndTempCashInvestments
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 14965749 | BOY |
| EOY | 15153492 | EOY |
Pledges And Grants Receivable PledgesAndGrantsReceivable
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 7298328 | BOY |
| EOY | 8012726 | EOY |
Accounts Receivable AccountsReceivable
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 385563 | BOY |
| EOY | 772245 | EOY |
Prepaid Expenses Deferred Charges PrepaidExpensesDeferredCharges
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 225459 | BOY |
| EOY | 236122 | EOY |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Land Buildings Equipment Basis | 62600670 | LandBuildingsEquipmentBasis |
| Land Bldg Equipment Accum Deprec | 29223226 | LandBldgEquipmentAccumDeprec |
Land Buildings Equipment Basis Net LandBuildingsEquipmentBasisNet
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 31125599 | BOY |
| EOY | 33377444 | EOY |
Other Assets Total OtherAssetsTotal
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 15663948 | BOY |
| EOY | 17976792 | EOY |
Total Assets TotalAssets
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 69664646 | BOY |
| EOY | 75528821 | EOY |
Accounts Payable Accrued Expenses AccountsPayableAccruedExpenses
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 7758745 | BOY |
| EOY | 6777563 | EOY |
Deferred Revenue DeferredRevenue
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 1679839 | BOY |
| EOY | 3106899 | EOY |
Tax Exempt Bond Liabilities TaxExemptBondLiabilities
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 25100671 | BOY |
| EOY | 10390000 | EOY |
Mort Notes Pybl Secured Invest Prop MortNotesPyblSecuredInvestProp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 1015000 | BOY |
| EOY | 20156490 | EOY |
Total Liabilities TotalLiabilities
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 35554255 | BOY |
| EOY | 40430952 | EOY |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Follow SFAS117 | X | FollowSFAS117 |
Unrestricted Net Assets UnrestrictedNetAssets
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 21811264 | BOY |
| EOY | 21449630 | EOY |
Temporarily Restricted Net Assets TemporarilyRestrictedNetAssets
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 3812326 | BOY |
| EOY | 4736875 | EOY |
Permanently Restricted Net Assets PermanentlyRestrictedNetAssets
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 8486801 | BOY |
| EOY | 8911364 | EOY |
Total Net Assets Fund Balances TotalNetAssetsFundBalances
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 34110391 | BOY |
| EOY | 35097869 | EOY |
Total Liab Net Assets Fund Balances TotalLiabNetAssetsFundBalances
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 69664646 | BOY |
| EOY | 75528821 | EOY |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Reconcilation Revenue Expenses | -254620 | ReconcilationRevenueExpenses |
| Reconciliation Unrealized Invest | 1242098 | ReconciliationUnrealizedInvest |
| Method Of Accounting Accrual | X | MethodOfAccountingAccrual |
| Accountant Compile Or Review | false | AccountantCompileOrReview |
| FS Audited | true | FSAudited |
FS Audited Basis FSAuditedBasis
| Field | Value | IRS element (for citing) |
|---|---|---|
| Financial Statement Separate | X | FinancialStatementSeparate |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Audit Committee | true | AuditCommittee |
| Federal Grant Audit Required | true | FederalGrantAuditRequired |
| Federal Grant Audit Performed | true | FederalGrantAuditPerformed |
Schedule A IRS990ScheduleA
| Field | Value | IRS element (for citing) |
|---|---|---|
| Medical Research Org170b1 Aiii | X | MedicalResearchOrg170b1Aiii |
Hospital Name And Address HospitalNameAndAddress
Name Name
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | Virginia Mason Medical Center | BusinessNameLine1 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| City | Seattle | City |
| State | WA | State |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Public Support Pertcentage170 | 0.00000 | PublicSupportPertcentage170 |
| Public Support Percentage509 | 0.00000 | PublicSupportPercentage509 |
| Investment Income Percentage | 0.00000 | InvestmentIncomePercentage |
Schedule B IRS990ScheduleB
Contributor Info ContributorInfo
| Field | Value | IRS element (for citing) |
|---|---|---|
| Contributor Number | RESTRICTED | ContributorNumber |
Contributor Name Business ContributorNameBusiness
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | RESTRICTED | BusinessNameLine1 |
Contributor Address US ContributorAddressUS
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | RESTRICTED | AddressLine1 |
| Address Line2 | RESTRICTED | AddressLine2 |
| City | RESTRICTED | City |
| State | RESTRICTED | State |
| ZIP Code | RESTRICTED | ZIPCode |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Aggregate Contributions | RESTRICTED | AggregateContributions |
Schedule C IRS990ScheduleC
| Field | Value | IRS element (for citing) |
|---|---|---|
| Org Belongs To Affiliated Group | X | OrgBelongsToAffiliatedGroup |
Total Grassroots Lobbying TotalGrassrootsLobbying
| Field | Value | IRS element (for citing) |
|---|---|---|
| Affiliated Group Totals | 127874 | AffiliatedGroupTotals |
Total Direct Lobbying TotalDirectLobbying
| Field | Value | IRS element (for citing) |
|---|---|---|
| Affiliated Group Totals | 6000 | AffiliatedGroupTotals |
Total Lobbying Expenditures TotalLobbyingExpenditures
| Field | Value | IRS element (for citing) |
|---|---|---|
| Affiliated Group Totals | 133874 | AffiliatedGroupTotals |
Other Exempt Purpose Expenditures OtherExemptPurposeExpenditures
| Field | Value | IRS element (for citing) |
|---|---|---|
| Filing Organizations Totals | 43645635 | FilingOrganizationsTotals |
| Affiliated Group Totals | 984166097 | AffiliatedGroupTotals |
Total Exempt Purpose Expenditures TotalExemptPurposeExpenditures
| Field | Value | IRS element (for citing) |
|---|---|---|
| Filing Organizations Totals | 43645635 | FilingOrganizationsTotals |
| Affiliated Group Totals | 984299971 | AffiliatedGroupTotals |
Lobbying Nontaxable LobbyingNontaxableAmount
| Field | Value | IRS element (for citing) |
|---|---|---|
| Filing Organizations Totals | 1000000 | FilingOrganizationsTotals |
| Affiliated Group Totals | 1000000 | AffiliatedGroupTotals |
Grassroots Nontaxable GrassrootsNontaxableAmount
| Field | Value | IRS element (for citing) |
|---|---|---|
| Filing Organizations Totals | 250000 | FilingOrganizationsTotals |
| Affiliated Group Totals | 250000 | AffiliatedGroupTotals |
Lobbying Nontaxable Amount2 LobbyingNontaxableAmount2
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Year Minus3 | 1000000 | CurrentYearMinus3 |
| Current Year Minus2 | 1000000 | CurrentYearMinus2 |
| Current Year Minus1 | 1000000 | CurrentYearMinus1 |
| Current Year | 1000000 | CurrentYear |
| Total | 4000000 | Total |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Lobbying Ceiling | $6,000,000 | LobbyingCeilingAmount |
Total Lobbying Expenditures2 TotalLobbyingExpenditures2
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Year Minus3 | 269422 | CurrentYearMinus3 |
| Current Year Minus2 | 270061 | CurrentYearMinus2 |
| Current Year Minus1 | 222311 | CurrentYearMinus1 |
| Current Year | 133874 | CurrentYear |
| Total | 895668 | Total |
Grassroots Nontaxable Amount2 GrassrootsNontaxableAmount2
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Year Minus3 | 250001 | CurrentYearMinus3 |
| Current Year Minus2 | 250000 | CurrentYearMinus2 |
| Current Year Minus1 | 250000 | CurrentYearMinus1 |
| Current Year | 250000 | CurrentYear |
| Total | 1000001 | Total |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grassroots Ceiling | $1,500,002 | GrassrootsCeilingAmount |
Grassroots Lobbying Expenditures GrassrootsLobbyingExpenditures
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Year Minus3 | 152146 | CurrentYearMinus3 |
| Current Year Minus2 | 151772 | CurrentYearMinus2 |
| Current Year Minus1 | 122311 | CurrentYearMinus1 |
| Current Year | 127874 | CurrentYear |
| Total | 554103 | Total |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Volunteers | false | Volunteers |
| Paid Staff Or Management | false | PaidStaffOrManagement |
| Media Advertisements | false | MediaAdvertisements |
| Mailings Members | false | MailingsMembers |
| Publications Or Broadcast | false | PublicationsOrBroadcast |
| Grants Other Organizations | false | GrantsOtherOrganizations |
| Direct Contact Legislators | false | DirectContactLegislators |
| Rallies Demonstrations | false | RalliesDemonstrations |
| Other Activities | false | OtherActivities |
| Not Described In501c3 | false | NotDescribedIn501c3 |
| Form4720 Filed4912 Tax | false | Form4720Filed4912Tax |
Form990 Schedule C Part IV Form990ScheduleCPartIV (4 entries)
| IdentifierIdentifier | Return ReferenceReturnReference | ExplanationExplanation |
|---|---|---|
| II-A | A | Benaroya Research Institute at Virginia Mason, EIN 91-0653422, 1201 Ninth Avenue, Seattle, WA 98101. Non-electing member. 0 Lobbying Expenditures. Excess Lobbying Expenditures 0. |
| II-A | A continued | Virginia Mason Medical Center, EIN 91-0565539, 1100 Ninth Avenue, Seattle, WA 98101. Election Member. Grassroots Lobbying Expenditures 127,874. Direct Lobbying Expenditures 6,000. Excess Lobbying Expenditures 0. Tax year ending December 31, 1998 was the first year in which Virginia Mason Medical Center made the election under Section 501h. The election was not revoked before the start of the tax year ending December 31, 2012. |
| II-A | A continued | Virginia Mason Health System, EIN 91-1351110, 1100 Ninth Avenue, Seattle, WA 98101. Non-electing member. 0 Lobbying Expenditures. Excess Lobbying Expenditures 0. |
| II-A | A continued | Virginia Mason Institute, EIN 26-3763656, 1100 Ninth Avenue, Seattle, WA 98101. Non-electing member. 0 Lobbying Expenditures. Excess Lobbying Expenditures 0. |
Schedule D IRS990ScheduleD
| Field | Value | IRS element (for citing) |
|---|---|---|
| Included On FS | false | IncludedOnFS |
Land Land
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | 756906 | OtherCostOrOtherBasis |
| Book Value | 756906 | BookValue |
Buildings Buildings
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | 45637796 | OtherCostOrOtherBasis |
| Depreciation | 17500699 | Depreciation |
| Book Value | 28137097 | BookValue |
Leasehold Improvements LeaseholdImprovements
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | 196862 | OtherCostOrOtherBasis |
| Depreciation | 196862 | Depreciation |
Equipment Equipment
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | 14582369 | OtherCostOrOtherBasis |
| Depreciation | 11525665 | Depreciation |
| Book Value | 3056704 | BookValue |
Other Land Buildings OtherLandBuildings
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | 1426737 | OtherCostOrOtherBasis |
| Book Value | 1426737 | BookValue |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Of Book Value Land Buildings | 33377444 | TotalOfBookValueLandBuildings |
Other Securities OtherSecurities (2 entries)
| DescriptionDescription |
|---|
| Financial derivatives and other financial products |
| Closely-held equity interests |
Other Assets OtherAssets (4 entries)
| DescriptionDescription | Book ValueBookValue |
|---|---|
| Interest in Net Assets of Virginia Mason Health System | 16667603 |
| Fringe benefit receivable | 729871 |
| Deferred financing costs, net | 534956 |
| Due from affiliates, net | 44362 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Book Value Other Assets | 17976792 | TotalBookValueOtherAssets |
Other Liabilities OtherLiabilities
| Field | Value | IRS element (for citing) |
|---|---|---|
| Description | Federal income taxes | Description |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Tot Revenue Etc Audited Fincl Stmt | 44633113 | TotRevenueEtcAuditedFinclStmt |
| Net Unrealized Gains Investments | 1242098 | NetUnrealizedGainsInvestments |
| Revenue Not Rptd F990 | 1242098 | RevenueNotRptdF990 |
| Revenue Subtotal | 43391015 | RevenueSubtotal |
| Total Revenue Per Form990 | 43391015 | TotalRevenuePerForm990 |
| Tot Expenses Etc Audited Fincl Stmt | 43645635 | TotExpensesEtcAuditedFinclStmt |
| Expenses Subtotal | 43645635 | ExpensesSubtotal |
| Total Expenses Per Form990 | 43645635 | TotalExpensesPerForm990 |
Schedule F IRS990ScheduleF
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grant Records Maintained | true | GrantRecordsMaintained |
Accts Actvs Out US Table AcctsActvsOutUSTable (4 entries)
| RegionRegion | Type Of Activities ConductedTypeOfActivitiesConducted | Specific Services ProvidedSpecificServicesProvided | Total ExpendituresTotalExpenditures |
|---|---|---|---|
| North America | Conferences | Medical Research | 1610 |
| East Asia and the Pacific | Conferences | Medical Research | 3707 |
| Europe | Conferences | Medical Research | 18122 |
| Central America and the Caribbean | Conferences | Medical Research | 2641 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Subtotal Amount Spent | 26080 | SubtotalAmountSpent |
| Total Amount Spent | 26080 | TotalAmountSpent |
Grants To Orgs Outside US GrantsToOrgsOutsideUS (3 entries)
| RegionRegion | Purpose Of GrantPurposeOfGrant | Amount Of Cash GrantAmountOfCashGrant | Manner Of Cash DisbursementMannerOfCashDisbursement |
|---|---|---|---|
| North America | Medical Research | 95290 | Wire Transfer |
| East Asia and the Pacific | Medical Research | 94013 | Wire Transfer |
| Europe | Medical Research | 24390 | Wire Transfer |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Number Of Other Orgs | 3 | TotalNumberOfOtherOrgs |
| Transfer To Foreign Corp | false | TransferToForeignCorp |
| Interest In Foreign Trust | false | InterestInForeignTrust |
| Own Foreign Corp | false | OwnForeignCorp |
| Passive Foreign Invest Co | false | PassiveForeignInvestCo |
| Foreign Partnership | false | ForeignPartnership |
| Boycott Countries | false | BoycottCountries |
Form990 Schedule F Part V Form990ScheduleFPartV (3 entries)
| IdentifierIdentifier | Return ReferenceReturnReference | ExplanationExplanation |
|---|---|---|
| I | 2 | Subrecipient Monitoring Policy - medical research sub awards - BRI has formal policies and procedures to assure full compliance with applicable policies and laws governing Federal Grants. The policy provides assurance that subrecipients comply with Federal Grant requirements. This policy requires subrecipients to provide annual audited reports that identify compliance with laws and regulations and have met the requirements of OMB Circular A-133. Management has communicated with an educated administrative staff regarding implementation of this policy. The Director of Grants and Contracts is responsible for monitoring subrecipient adherence to financial regulations which includes the annual A-133 audit. The principal investigator is responsible for overseeing the satisfactory performance of the sub-award to ensure that goals are achieved. If there are unusual or unforeseen items, these will be investigated. |
| I | 3f | The expenditures were actual expenses incurred in the region based on individual expense reports and tracking of expenditures by grant or department on the accrual basis of accounting. |
| II | 1 | The expenditures were expenses incurred in the region based on award goals on the accrual basis of accounting. |
Schedule I IRS990ScheduleI
| Field | Value | IRS element (for citing) |
|---|---|---|
| Records Maintained | true | RecordsMaintained |
Recipient Table RecipientTable (19 entries)
| Address Line1AddressUS/AddressLine1 | CityAddressUS/City | StateAddressUS/State | ZIP CodeAddressUS/ZIPCode | EIN Of RecipientEINOfRecipient | IRC SectionIRCSection | Amount Of Cash GrantAmountOfCashGrant | Purpose Of GrantPurposeOfGrant |
|---|---|---|---|---|---|---|---|
| Blood Systems Research | |||||||
| 270 Masonic Ave | San Francisco | CA | 94114 | 860098929 | 501c3 | 17668 | Medical Research |
| California Institute of Technology | |||||||
| 1200 E California Blvd | Pasadena | CA | 91125 | 951643307 | 501c3 | 140522 | Medical Research |
| Duke University | |||||||
| Subcontractor Inst AR | Charlotte | NC | 28260 | 560532129 | 501c3 | 121735 | Medical Research |
| La Jolla Inst for Allergy & Immun | |||||||
| 9420 Athena Circle | La Jolla | CA | 92037 | 330328688 | 501c3 | 49970 | Medical Research |
| Lab Key Software | |||||||
| 2226 Eastlake Ave E | Seattle | WA | 98102 | 208266728 | 959581 | Medical Research | |
| Oregon HSU | |||||||
| 0690 SW Bancroft St | Portland | OR | 97239 | 931176109 | Oregon | 70572 | Medical Research |
| Rockefeller University | |||||||
| 1230 York Ave Box 259 | New York | NY | 10021 | 131624158 | 501c3 | 18841 | Medical Research |
| Seattle Biomedical Res Inst | |||||||
| 307 Westlake Ave N Ste 500 | Seattle | WA | 98072 | 910961784 | 501c3 | 143933 | Medical Research |
| Seattle Childrens Hospital | |||||||
| PO Box 24728 | Seattle | WA | 98124 | 910564748 | 501c3 | 465841 | Medical Research |
| The Res Inst at Nationwide | |||||||
| 700 Childrens Drive | Columbus | OH | 43271 | 316056230 | 501c3 | 153744 | Medical Research |
| UC Regents Univ of California | |||||||
| 9500 Gilman Drive | La Jolla | CA | 92093 | 956006144 | California | 45008 | Medical Research |
| University of Colorado | |||||||
| PO Box 910238 | Denver | CO | 80291 | 846000555 | 501c3 | 97476 | Medical Research |
| Univ of Florida Board of Trustee | |||||||
| PO Box 113001 | Gainsville | FL | 32611 | 596002052 | 501c3 | 60104 | Medical Research |
| Univ of Kentucky Res Fndn | |||||||
| 301 Peterson Svc Bldg | Lexington | KY | 40506 | 616033693 | 501c3 | 12373 | Medical Research |
| University of Pennsylvania | |||||||
| PO Box 785541 | Philadelphia | PA | 19178 | 231352685 | Pennsylvania | 157794 | Medical Research |
| University of Rochester | |||||||
| 910 Genesee St Ste 200 | Rochester | NY | 14611 | 160743209 | New York | 14159 | Medical Research |
| University of Virginia | |||||||
| PO Box 400195 | Charlottesville | VA | 22904 | 546001796 | Virginia | 34856 | Medical Research |
| University of WA Grants | |||||||
| 12455 Collections Dr | Chicago | IL | 60693 | 916001537 | Washington | 1418869 | Medical Research |
| Yale University | |||||||
| PO Box 1873 | New Haven | CT | 06508 | 080648973 | 501c3 | 20390 | Medical Research |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Nbr Of501 C3 And Govt Grants | 18 | TotalNbrOf501C3AndGovtGrants |
| Total Nbr Of Other Organizations | 1 | TotalNbrOfOtherOrganizations |
Form990 Schedule I Part IV Form990ScheduleIPartIV
| Field | Value | IRS element (for citing) |
|---|---|---|
| Identifier | I | Identifier |
| Return Reference | 2 | ReturnReference |
| Explanation | Subrecipient Monitoring Policy - medical research sub awards - BRI has formal policies and procedures to assure full compliance with applicable policies and laws governing Federal Grants. The policy provides assurance that subrecipients comply with Federal Grants requirements. This policy requires subrecipients to provide annual audited reports that identify compliance with laws and regulations and have met the requirements of OMB Circular A-133. Management has communicated with an educated administrative staff regarding implementation of this policy. The Director of Grants and Contracts is responsible for monitoring subrecipient adherence to financial regulations which includes the annual A-133 audit. The principal investigator is responsible for overseeing the satisfactory performance of the sub-award to ensure that goals are achieved. If there are unusual or unforeseen items, these will be investigated. | Explanation |
Schedule J IRS990ScheduleJ
| Field | Value | IRS element (for citing) |
|---|---|---|
| Severance Payment | false | SeverancePayment |
| Supplemental Nonqual Retire Plan | true | SupplementalNonqualRetirePlan |
| Equity Based Comp Arrangement | false | EquityBasedCompArrangement |
| Comp Based On Revenue Of Filing Org | false | CompBasedOnRevenueOfFilingOrg |
| Comp Based On Revenue Related Orgs | false | CompBasedOnRevenueRelatedOrgs |
| Comp Based Net Earnings Filing Org | false | CompBasedNetEarningsFilingOrg |
| Comp Based Net Earnings Relate Orgs | false | CompBasedNetEarningsRelateOrgs |
| Any Non Fixed Payments | false | AnyNonFixedPayments |
| Initial Contract Exception | false | InitialContractException |
Form990 Schedule J Part II Form990ScheduleJPartII (12 entries)
| TitleTitle | Base Compensation Filing OrgBaseCompensationFilingOrg | Deferred Comp Filing OrgDeferredCompFilingOrg | Nontaxable Benefits Filing OrgNontaxableBenefitsFilingOrg | Total Compensation Filing OrgTotalCompensationFilingOrg | Bonus Filing OrgBonusFilingOrg | Comp Based On Related OrgsCompBasedOnRelatedOrgs | Bonus Related OrgsBonusRelatedOrgs | Other Compensation Related OrgsOtherCompensationRelatedOrgs | Deferred Comp Related OrgsDeferredCompRelatedOrgs | Nontaxable Benefits Related OrgsNontaxableBenefitsRelatedOrgs | Total Compensation Related OrgsTotalCompensationRelatedOrgs |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Carla Greenbaum MD | |||||||||||
| Director | 205255 | 22500 | 8403 | 236158 | |||||||
| Gerald Nepom MD PhD | |||||||||||
| Ex Officio | 367442 | 39500 | 1836 | 512744 | 103966 | ||||||
| Joyce Lammert MD PhD | |||||||||||
| Director | 422477 | 123436 | 18288 | 34638 | 13854 | 612693 | |||||
| John Corman MD | |||||||||||
| Director | 500214 | 100 | 270 | 45849 | 23608 | 570041 | |||||
| Gary Kaplan MD | |||||||||||
| Ex Officio | 1039978 | 449871 | 17788 | 2199932 | 30109 | 3737678 | |||||
| Homer Lane Jr | |||||||||||
| Executive Director and Chief Financial Officer | 208911 | 10462 | 7450 | 227150 | 327 | ||||||
| Jack Nagan | |||||||||||
| Executive Director | 216911 | 26000 | 3496 | 324658 | 78251 | ||||||
| Jane Buckner MD | |||||||||||
| Research Member | 210116 | 22500 | 2556 | 235172 | |||||||
| William Kwok PhD | |||||||||||
| Research Member | 202031 | 22500 | 3852 | 228943 | 560 | ||||||
| Jason Wood | |||||||||||
| Chief Information Officer | 168902 | 13639 | 182541 | ||||||||
| Thomas Wight PhD | |||||||||||
| Research Member | 175457 | 22500 | 14876 | 213393 | 560 | ||||||
| Steven Ziegler PhD | |||||||||||
| Research Member | 182602 | 13675 | 5976 | 202813 | 560 | ||||||
Form990 Schedule J Part III Form990ScheduleJPartIII (2 entries)
| IdentifierIdentifier | Return ReferenceReturnReference | ExplanationExplanation |
|---|---|---|
| I | 3 | Benaroya Research Institute at Virginia Mason relies upon Virginia Mason Medical Centers a related organization Board Compensation and Benefits Committee, a committee composed of independent board members to whom the Board has delegated the authority to approve all compensation and benefits for the executive leaders of the Medical Center. To ensure that such benefit plans are market competitive and reasonable, the Committee receives support and advice, including appropriate market comparability data, from an independent compensation consultant with expertise in the health care industry and access to relevant market data. See Schedule O for additional disclosure. |
| I | 4b | The Medical Center has a Supplemental Executive Retirement Plan SERP. The SERP is a 457f nonqualified deferred compensation plan pursuant to which plan benefits are subject to a substantial risk of forfeiture, entered into when certain senior executives join the Medical Center. The plan was approved by the Boards Compensation and Benefits Committee, a committee composed of independent board members to whom the Board delegates the authority to approve compensation and benefits for the Medical Centers most senior executives. The Committee receives advice from an independent compensation consultant to ensure that compensation and benefits, including the SERP, are market competitive and reasonable. |
Schedule K IRS990ScheduleK
Form990 Schedule K Part I Form990ScheduleKPartI
| Field | Value | IRS element (for citing) |
|---|---|---|
| Bond Reference | A | BondReferenceCd |
Issuer Name IssuerName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | WA Econ Devel Fin Auth-2012 Series B | BusinessNameLine1 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Issuer EIN | 911493002 | IssuerEIN |
| Date Issued | 2012-06-01 | DateIssued |
| Issue Price | 10390000 | IssuePrice |
| Description Of Purpose | See Part VI | DescriptionOfPurpose |
| Defeased | false | Defeased |
| On Behalf Of Issuer | true | OnBehalfOfIssuer |
| Pool Financing | false | PoolFinancing |
Form990 Schedule K Part II Form990ScheduleKPartII
| Field | Value | IRS element (for citing) |
|---|---|---|
| Bond Reference | A | BondReferenceCd |
| Total Proceeds | 10390348 | TotalProceeds |
| Capital Expenditures | 2550348 | CapitalExpenditures |
| Current Refunding | true | CurrentRefunding |
| Advance Refunding | false | AdvanceRefunding |
| Final Allocation Made | true | FinalAllocationMade |
| Adequate Books And Recds Maintaind | true | AdequateBooksAndRecdsMaintaind |
Form990 Schedule K Part III Form990ScheduleKPartIII
| Field | Value | IRS element (for citing) |
|---|---|---|
| Bond Reference | A | BondReferenceCd |
| Owning Bond Financed Property | false | OwningBondFinancedProperty |
| Any Lease Arrangements | true | AnyLeaseArrangements |
| Mngment Cntrct Bond Financd Prprty | false | MngmentCntrctBondFinancdPrprty |
| Any Research Agreements | true | AnyResearchAgreements |
| Engage Bond Counsel Research | true | EngageBondCounselResearch |
| Prcntge Prvt Business Use By Others | 0.00800 | PrcntgePrvtBusinessUseByOthers |
| Total Private Business Use | 0.00800 | TotalPrivateBusinessUse |
| Bond Iss Meet Prvt Security Pay Test | true | BondIssMeetPrvtSecurityPayTest |
| Change In Use Bond Financed Prop | false | ChangeInUseBondFinancedProp |
| Non Qualified Bond Remed Procdrs | false | NonQualifiedBondRemedProcdrs |
Form990 Schedule K Part IV Form990ScheduleKPartIV
| Field | Value | IRS element (for citing) |
|---|---|---|
| Bond Reference | A | BondReferenceCd |
| Form8038 T Filed | false | Form8038TFiled |
| Rebate Not Due Yet | true | RebateNotDueYet |
| Variable Rate Issue | false | VariableRateIssue |
| Hedge Identified In Books And Recds | false | HedgeIdentifiedInBooksAndRecds |
| Gross Proceeds Invested In GIC | false | GrossProceedsInvestedInGIC |
| Gross Proceeds Invested | false | GrossProceedsInvested |
| Written Proc To Monitor Reqs | false | WrittenProcToMonitorReqs |
Form990 Schedule K Part V Form990ScheduleKPartV
| Field | Value | IRS element (for citing) |
|---|---|---|
| Bond Reference | A | BondReferenceCd |
| Proc To Undertk Corrective Action | false | ProcToUndertkCorrectiveAction |
Form990 Schedule K Part VI Form990ScheduleKPartVI (2 entries)
| IdentifierIdentifier | Return ReferenceReturnReference | ExplanationExplanation |
|---|---|---|
| I | A f | Purposes to currently refund WEDFA Series 2006C bonds issued 11/15/2006, and to fund research facility improvements. |
| II | 3 | Difference between Part I, column e and Part II, Line 3 is investment earnings. |
Schedule O IRS990ScheduleO
General Explanation GeneralExplanation (8 entries)
| ExplanationExplanation |
|---|
| Form 990 Part III Line 1 Benaroya Research Institute at Virginia Mason BRI is a world-renowned medical research institute whose work has resulted in major advances against 80 autoimmune diseases. One in 20 Americans suffers from one or more autoimmune diseases, such as type 1 diabetes, multiple sclerosis, Crohns disease and rheumatoid arthritis to name a few. Because all autoimmune diseases are connected in the way the immune system attacks the body, BRI scientists arent focused on eliminating one or two autoimmune diseases - they are taking on many more. As a world leader in scientific innovation, BRIs discoveries are having significant impact on people living with autoimmune diseases today - by improving the ability to predict disease risk, decreasing disease progression and making therapies safer and better. |
| Form 990 Part III Line 4a One of the unique qualities of BRI is the close integration of three types of medical research - laboratory research, translational research and clinical research - to improve peoples lives. Our scientists can address both the basic science issues and clinical applications, which is the best way to design studies with the highest potential for success. For BRI, discovery starts in the laboratory. A Laboratory advances in 2012 include 1 A breakthrough discovery of how allergy shots steer the immune response to prevent allergies. These findings open new horizons for understanding allergic disease and improving safety and efficacy of current allergy shots. 2 Decoding how a common change in a gene called PTPN22 may predispose children and adults to develop autoimmune diseases including Type 1 diabetes, rheumatoid arthritis and lupus. A team of researchers from BRI and Seattle Childrens are now testing how this gene may help predict the people who are at risk for autoimmune conditions and whether a therapy can be developed to compensate for this genetic change. 3 Finding a new complexity in the immune system - a mirror regulatory cell for each kind of helper T cell to tell it how to respond. 4 Discovery of a molecular pathway to regulate macrophages - cells in the immune system that are some of the first responders at sites of injury, infection and inflammation. B Translational research is the link between laboratory research and clinical research, built upon an exchange of materials and information between these two disciplines. BRI scientists and collaborators work together to study blood and serum samples along with medical and demographic data collected from people with autoimmune and immune-mediated diseases. These include multiple sclerosis, type 1 diabetes, lupus, rheumatoid arthritis, inflammatory bowel disease, allergy and asthma. BRI maintains an extensive biorepository with samples dating back to 2000, including 11 disease categories and a biorepository of healthy people for comparison purposes. Advancements in 2012 include the following 1 BRI established a new translational research core laboratory called the Human Immunophenotyping Core. Scientists use this core to identify the underlying mechanisms of disease and develop biomarkers of disease. The core is also a designated laboratory for the Immune Tolerance Network ITN. BRI Director Gerald T. Nepom, MD, PhD, serves as the director of the ITN, one of the largest government-funded clinical research networks in the nation working to accelerate new treatments for diseases of the immune system. 2 The BRI Diabetes Research Program received a 4.4 million grant from the Leona M. and Harry B. Helmsley Charitable Trust to establish the T1D Exchange Biobank Operations Center. 3 BRI scientists began new partnerships with several biopharmaceutical companies to potentially speed up translational research of diagnosis and treatment of autoimmune and immune-mediated diseases. C Clinical research studies are conducted with volunteers who participate in experimental medical approaches not available outside the clinical trial setting, and play a major role in pushing the boundaries of knowledge about their disease and new therapies. BRI conducts nearly 100 trials each year in many different diseases through a Diabetes Research Program partnership with Seattle Childrens , TrialNet and the National Institutes of Health trials with the Immune Tolerance Network and the BRI Clinical Research Program with physicians at Virginia Mason. Advancements in 2012 include 1 Multiple sclerosis research. Participation in clinical trials led to the FDA approval of a second oral agent teriflunomide for multiple sclerosis and a third anticpated in 2013. Studies in 2013 will focus on the possibility of remyelination as well as impact of treatment on brain volume measurements. Translational work also remains active with exploration of biomarkers to guide treatment decisions. 2 Rheumatology research. BRI was part of the pivotal trials for the first drug in a new class of immunotherapies called JAK inhibitors. This is the first oral medication to be approved in a number of years and the only major drug approved for rheumatoid arthritis in 2012. 3 Type 1 diabetes research. Clinical trials included the study of an artifical pancreas, new experimental drugs to modify the immune response, whether vitamin D can change how immune cells function, better ways to measure insulin secretion and how best to monitor patients at risk of developing type 1 diabetes. D Prevention is the ultimate goal of early diagnosis, before autoimmune diseases become a clinical problem. One of the important lessons learned in BRIs quest to diagnose, better treat and cure autoimmune diseases is that the earlier intervention, the better. Several pioneering advancements at BRI in 2012 focused on prevention 1 Calculating an individualss risk for the development of type 1 diabetes through the publication of a practical algorithm by BRI and collaborators at TrialNet. With this discovery, at-risk people can be closely monitoried and have opportunities to enter a prevention trial. 2 Exploring how to interrupt the immune process that causes the destruction of insulin secreting beta cells in the pancreas during the pre-diabetic state and thereby prevent or delay the onset of type 1 diabetes. BRI is participating in an experimental drug therapy prevention trial sponsored by TrialNet offered to relatives of people with diabetes who are themselves at very high risk for developing the disease. 3 Researching how to restore balance between good and harmful cells involved in initiating disease, by regulating the immune response. BRI will lead a 2.6 million study to understand how the immune system becomes unbalanced and how it might be manipulated in people with autoimmune diseases. 4 Looking for the genetic roots of type 1 diabetes. three different research strategies are being used together to follow the precise molecular steps that are caused by susceptibility genes associated with type 1 diabetes, in a new 4.3 million grant to BRI investigators. 5 Identifying key infectious triggers and regulators of a molecule called TSLP, a key component of the early immune response in the lung airways leading to asthma and allergies. E Immunology research is driving toward individualized treatment for each person with autoimmune and immune-mediated diseases. Each persons genetics, environment and immune system mechanisms are unique, and people react to therapies differently and their responses may change over time. The optimal approach will be to individualize health care for each person and offer the right treatment at the right time. BRI is leading several worldwide efforts to personalize medicine 1 Developing a way to provide an immune system profile for individual patients. The profile will detail the expression of thousands of genes over a persons lifetime. The goal is to provide an early warning of things to come and an indication of what treatments might be needed. In 2012, the development of a low-cost genomic fingerprinting assay enabled BRI researchers to generate immune signatures of hundreds of patients with infectious and autoimmune diseases. Such an assay may on day make its way to the clinic where tools for evaluating immune health are critically needed. 2 Development of new biomarkers to allow individualized studies of responses to vaccines and food allergies.k Biomarkers were also developed to study individuals with the highest level of risk for developing type 1 diabetes. BRI serves as the inventor and international leader for the production and application of biomarkers that have contributed to a broad array of scientific advances, including the study of individual immune responses to better understand disease and how to personlize treatment. |
| Form 990 Part VI Section A Line 1a The governing body delegates to an Executive Committee comprised of four officers of the Board and the Chairs of each standing Board Committee, the authority of the Board of Directors in the management of the corporation as may be deemed by the Executive Committee to be appropriate, to be exercised in time periods between regularly scheduled meetings of the Board of Directors. The Director and the Executive Director of the corporation serve as ex officio members of the Executive Committee, without voting rights. The Executive Committee does not have the authority to amend, alter or repeal the bylaws elect, appoint or removed any member of such Executive Committee or any director or officer of the corporation amend the articles of incorporation adopt a plan of merger or adopt a plan of consolidation with another corporation authorize the sale, lease or exchange of all or substantially all the property and assets of the corporation not in the ordinary course of business authorize the voluntary dissolution of the corporation or revoke proceedings therefore adopt a plan for the distribution of the assets of the corporation or amend, alter or repeal any resolution of the Board which by its terms provides that it shall not be amended, altered or repealed by such Executive Committee. The Executive Committee also serves as the planning committee for the Board of Directors and oversees any compliance issues raised by the Board of Directors. |
| Form 990 Part VI Section A Line 6, 7 Virginia Mason Health System VMHS is the sole corporate member of Benaroya Research Institute at Virginia Mason BRI. VMHS as the sole voting member has the following approval rights 1 Election or appointment of Directors and Officers of the Board of Directors 2 Removal of Directors and Officers of the Board of Directors including any executive officer of the corporation 3 Approval of all long-range and short-range plans proposed by the Board of Directors 4 Approval of the annual capital and operating budgets proposed by the Board of Directors 5 Approval of the borrowing of funds where the amount borrowed is in excess of Five Hundred Thousand Dollars 500,000 6 Approval of the salel, lease, exchange, mortgage, pledge or disposal of all or substantially all of the property and assets 7 Approval of all amendments to or repeal of the Agreement Association or the Bylaws of the corporation 8 All other rights and powers as specified in the Washington Nonprofit Corporation Act. |
| Form 990 Part VI Section B Line 11B Review of the Form 990 Process. The Virginia Mason Health System Audit and Compliance Committee ACC, a committee composed of independent community members has been delegated responsibility for oversight of the annual Form 990 preparation process including 1 selection, engagement, and review of the performance of the independent tax preparer, 2 review of the annual draft Form 990 tax return, and 3 recommendation of the final Form 990 tax return for review to the BRI Board of Directors. Annually, at the September meeting, management and the tax preparer provides the ACC with an initial draft of the Form 990 and present an overview of the Form 990 preparation process. The final draft Form 990 is reviewed and approved by the ACC in November followed by a Board review of the final Form 990 prior to filing. The final Form 990 tax return is provided to each member of the Board of Directors via electronic delivery. |
| Form 990 Part VI Section B Line 12C The Virginia Mason Health System Governance Committee has been delegated accountability for oversight of the process for disclosure, evaluation and management of conflict of interest involving any member of the Benaroya Research Institute at Virginia Mason Board of Directors, executive leadership or key employees Covered Person. Pursuant to the Conflict of Interest Policy, an annual conflict of interest questionnaire is distributed to all Covered Persons. In addition, a Covered Person has an on-going duty to disclose the existence of a conflict of interest at any time an actual or potential conflict arises. Each Covered Person is required upon appointment and annually thereafter to attest to a statement that affirms that such person has 1 received a copy of the Conflict of Interest Policy 2 has read and understands the Policy 3 has agreed to comply with the Policy and 4 understands that BRI is a charitable organization and that in order to maintain its federal tax exemption must engage in activities that accomplish its tax-exempt purposes. Written disclosures are reviewed by the Governance Committee to determine if an actual or potential conflict of interest exists and if so, how it should be managed. The Covered Person is informed in writing regarding the determination the Conflict of Interest Management Plan. No Covered Person with an actual or potential conflict of interest shall engage in an activity on BRIs behalf related to the disclosed actual or potential Conflict of Interest unless such activity is permitted by the Conflict of Interest Management Plan or until the Covered Person has undertaken all steps set forth in the Management Plan to manage, reduce or eliminate the conflict. All Covered Persons have a duty to disclose the existence of any actual or potential conflict of interest with respect to meeting agenda items. The Conflict of Interest Policy requires that copies of the Conflict of Interest Questionnaires be completed annually by each Covered Person and any Conflict of Interest Management Plan be maintained. |
| Form 990 Part VI Section B Line 15 The VMHS Compensation and Benefits Board Committee, a committee composed solely of independent directors none of whom have a conflict of interest, is accountable for setting reasonable total compensation packages for each executive, officer and key employee Executive consistent with VMHS/BRIs philosophy and principles. The Committee approves annual goals and performance criteria which are used in determining merit increases and variable compensation opportunities. The Committees assesses performance against these goals. The Committee selects and engages a qualified independent compensation consultant to review and analyze the total compensation and benefits packages of the Executives. The Committee as part of its analysis obtains from the compensation consultant appropriate comparability data including total compensation paid by similarly situated organizations for positions that are functionally comparable to each of the Executives. The Committee will consider the significant terms of the agreement with each Executive including the total compensation to be paid and the employees duties and responsibilities. Consistent with VMHS/BRIs compensation philosophy and principles, the Committee approves total compensation packages for each of the Executives based on information presented to the Committee, reasonableness and the best interest of BRI. The Committees decisions regarding compensation for each Executive are documented in written resolutions and minutes of the Committee. The Committee promptly reports its actions to the VMHS board which reports are reflected in the Boards minutes. The individuals who were reviewed in 2012 were the Board Director, Carla Greenbaum, the Executive Director and Chief Financial Officer, and Vice President and Research Executive Director. |
| Form 990 Part VI Section C Line 19 The organizations Articles, Bylaws, Conflicts of Interest Policy and financial statements are made available upon request. |
Schedule R IRS990ScheduleR
Form990 Schedule R Part II Form990ScheduleRPartII (2 entries)
| Address Line1AddressUS/AddressLine1 | CityAddressUS/City | StateAddressUS/State | ZIP CodeAddressUS/ZIPCode | EINEIN | Primary ActivitiesPrimaryActivities | Legal Domicile StateLegalDomicileState | Exempt Code SectionExemptCodeSection | Public Charity StatusPublicCharityStatus | Direct Controlling Entity NADirectControllingEntityNA | Controlled OrgControlledOrg | Business Name Line1DirectControllingEntityName/BusinessNameLine1 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Virginia Mason Health System (VMHS) | |||||||||||
| 1100 Ninth Ave | Seattle | WA | 98101 | 911351110 | Fundraising | WA | Sec 501c3 | 7-Support General Pu | N/A | true | |
| Virginia Mason Medical Center | |||||||||||
| 1100 Ninth Ave | Seattle | WA | 98101 | 910565539 | Health Care | WA | Sec 501c3 | 3-Hospital | false | VMHS | |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Receipt Of Int Ann Rents Royalties | false | ReceiptOfIntAnnRentsRoyalties |
| Gift Grant Or Cap Contr To Other Org | false | GiftGrantOrCapContrToOtherOrg |
| Gift Grant Or Cap Contr Fr Other Org | true | GiftGrantOrCapContrFrOtherOrg |
| Loans Or Guarantees To Other Org | false | LoansOrGuaranteesToOtherOrg |
| Loans Or Guarantees From Other Org | false | LoansOrGuaranteesFromOtherOrg |
| Dividends Related Organization | false | DividendsRelatedOrganization |
| Sale Of Assets To Other Org | false | SaleOfAssetsToOtherOrg |
| Purchase Of Assets From Other Org | false | PurchaseOfAssetsFromOtherOrg |
| Exchange Of Assets | false | ExchangeOfAssets |
| Rental Of Facilities To Other Orgs | true | RentalOfFacilitiesToOtherOrgs |
| Rental Of Facilities Fr Other Orgs | true | RentalOfFacilitiesFrOtherOrgs |
| Perform Of Services For Other Orgs | false | PerformOfServicesForOtherOrgs |
| Perform Of Services By Other Orgs | false | PerformOfServicesByOtherOrgs |
| Sharing Of Facilities | true | SharingOfFacilities |
| Sharing Of Paid Employees | false | SharingOfPaidEmployees |
| Reimbursement Paid To Other Org | true | ReimbursementPaidToOtherOrg |
| Reimbursement Paid By Other Org | true | ReimbursementPaidByOtherOrg |
| Other Transfer To Other Org | false | OtherTransferToOtherOrg |
| Other Transfer From Other Org | false | OtherTransferFromOtherOrg |
Affiliated Group Schedule AffiliatedGroupSchedule
Affiliated Schedule AffiliatedSchedule (4 entries)
| Address Line1AddressUS/AddressLine1 | CityAddressUS/City | StateAddressUS/State | ZIP CodeAddressUS/ZIPCode | EINEIN | Total Grassroots LobbyingTotalGrassrootsLobbying | Total Direct LobbyingTotalDirectLobbying | Total Lobbying ExpendituresTotalLobbyingExpenditures | Other Exempt Purpose ExpendituresOtherExemptPurposeExpenditures | Total Exempt Purpose ExpendituresTotalExemptPurposeExpenditures | Lobbying NontaxableLobbyingNontaxableAmount | Grassroots NontaxableGrassrootsNontaxableAmount | Tot Lobbying Grassroot Minus NontxTotLobbyingGrassrootMinusNontx | Tot Lobby Expend Mns Lobbying NontxTotLobbyExpendMnsLobbyingNontx | Share Of Excess Lobbying ExpendtrsShareOfExcessLobbyingExpendtrs | Electing OrgElectingOrg |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Benaroya Research Institute at Virginia Mason | |||||||||||||||
| 1201 Ninth Avenue | Seattle | WA | 98101 | 910653422 | 0 | 0 | 0 | 43645635 | 43645635 | $44,342 | $11,086 | 0 | 0 | 0 | |
| Virginia Mason Medical Center | |||||||||||||||
| 1100 Ninth Avenue | Seattle | WA | 98101 | 910565539 | 127874 | 6000 | 133874 | 924077890 | 924211764 | $938,953 | $234,738 | 0 | 0 | 0 | X |
| Virginia Mason Health System | |||||||||||||||
| 1100 Ninth Avenue | Seattle | WA | 98101 | 911351110 | 0 | 0 | 0 | 13866752 | 13866752 | $14,088 | $3,522 | 0 | 0 | 0 | |
| Virginia Mason Institute | |||||||||||||||
| 1100 Ninth Avenue | Seattle | WA | 98101 | 263763656 | 0 | 0 | 0 | 2575820 | 2575820 | $2,617 | $654 | 0 | 0 | 0 | |